BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3555956)

  • 1. A within patient cross over trial of 4 insulin regimens in antibody-negative, C-peptide negative patients.
    Oswald GA; Yudkin JS
    Diabetes Res; 1987 Feb; 4(2):85-9. PubMed ID: 3555956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human ultralente insulin: a comparison with porcine lente insulin as a twice-daily insulin in insulin-dependent diabetic patients with fasting hyperglycaemia.
    Francis AJ; Hanning I; Alberti KG
    Diabetes Res; 1986 Jun; 3(5):263-8. PubMed ID: 3527523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of conventional twice daily subcutaneous insulin administration and a multiple injection regimen (using the NovoPen) in insulin-dependent diabetes mellitus.
    Small M; MacRury S; Boal A; Paterson KR; MacCuish AC
    Diabetes Res; 1988 Jun; 8(2):85-9. PubMed ID: 3067951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved glycaemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetes.
    Clements MR; Tits J; Kinsley BT; Råstam J; Friberg HH; Ligthelm RJ
    Diabetes Obes Metab; 2008 Mar; 10(3):229-37. PubMed ID: 18269638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart.
    Ashwell SG; Gebbie J; Home PD
    Diabet Med; 2006 Aug; 23(8):879-86. PubMed ID: 16911626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.
    Schütt M; Kern W; Krause U; Busch P; Dapp A; Grziwotz R; Mayer I; Rosenbauer J; Wagner C; Zimmermann A; Kerner W; Holl RW;
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):384-8. PubMed ID: 16915542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability of blood glucose levels in patients with type 1 diabetes mellitus on intensified insulin regimens.
    Moberg EA; Lins PE; Adamson UK
    Diabete Metab; 1994; 20(6):546-52. PubMed ID: 7713278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two intensified conventional insulin regimens with three and four daily injections.
    Faglia E; Favales F; Brivio M; Calia P; Quarantiello A
    Diabete Metab; 1993; 19(6):575-81. PubMed ID: 8026609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
    Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
    J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does an insulin pen improve the metabolic control of type 1 diabetes mellitus if added to conventional treatment?
    Roos AN; Meinders AE
    Neth J Med; 1989 Apr; 34(3-4):116-25. PubMed ID: 2657451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of insulin-dependent diabetes using an injection pen: control, problems and patient preferences.
    Fisken RA; Goulbourn J
    Diabetes Res; 1989 Aug; 11(4):195-7. PubMed ID: 2696619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of once daily insulin injection regimes in the treatment of elderly diabetics.
    Roland JM; Lewin IG; O'Brien IA; Markanday S; Kurtz AB; Corrall RJ
    Diabetes Res; 1987 Mar; 4(3):131-4. PubMed ID: 3301160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evidence for a high incidence of nocturnal hypoglycaemia in IDDM: no effect of dose for dose transfer between human and porcine insulins.
    George E; Bedford C; Peacey SR; Hardisty CA; Heller SR
    Diabet Med; 1997 Jun; 14(6):442-8. PubMed ID: 9212308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biphasic insulin aspart given thrice daily is as efficacious as a basal-bolus insulin regimen with four daily injections: a randomised open-label parallel group four months comparison in patients with type 2 diabetes.
    Ligthelm RJ; Mouritzen U; Lynggaard H; Landin-Olsson M; Fox C; le Devehat C; Romero E; Liebl A
    Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):511-9. PubMed ID: 17115349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of insulin mixtures in type I diabetics: influence of the intermediate acting insulin on the action of short acting insulin.
    Goicolea I; Quiroga A; Vazquez JA
    Diabete Metab; 1987; 13(4):467-70. PubMed ID: 3315768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study.
    Meneghini L; Koenen C; Weng W; Selam JL
    Diabetes Obes Metab; 2007 Nov; 9(6):902-13. PubMed ID: 17924873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes.
    Haak T; Tiengo A; Draeger E; Suntum M; Waldhäusl W
    Diabetes Obes Metab; 2005 Jan; 7(1):56-64. PubMed ID: 15642076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin replacement therapy for the rat model of streptozotocin-induced diabetes mellitus.
    Haughton CL; Dillehay DL; Phillips LS
    Lab Anim Sci; 1999 Dec; 49(6):639-44. PubMed ID: 10638500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial.
    Charbonnel BH; Matthews DR; Schernthaner G; Hanefeld M; Brunetti P;
    Diabet Med; 2005 Apr; 22(4):399-405. PubMed ID: 15787663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.